Olulanu H. Aina

Springhouse — United States

Medicine · Health Sciences

17h-index1.5kcitations60works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(23), Cancer Treatment and Pharmacology(22), Angiogenesis and VEGF in Cancer(21), Monoclonal and Polyclonal Antibodies Research(13), Radiomics and Machine Learning in Medical Imaging(12)

Publications60 total

Supplementary Table 6 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 7 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 6 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 7 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 2 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 4 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 1 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 1 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 8 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 3 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 14 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 2 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 4 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 13 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 3 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Table 5 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 5 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 11 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Data from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
Supplementary Figure 10 from Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves <i>In Vivo</i> Efficacy and Tolerability
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Shalom D. Goldberg(18), Tero Satomaa(18), Olli Aitio(18), Krista Burke(18), Vadim Dudkin(18), Brian Geist(18), Onyi Irrechukwu(18), Anna‐Liisa Hänninen(18), Annamari Heiskanen(18), Jari Helin(18), Jukka O. Hiltunen(18), Jacqueline Kinyamu-Akunda(18), Donna M. Klein(18), Neeraj Kohli(18), Titta Kotiranta(18), Tuula Lähteenmäki(18), Ritva Niemelä(18), Virve Pitkänen(18), Henna Pynnönen(18), William Rittase(18)